BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30822414)

  • 41. A green tea polyphenol epigallocatechin-3-gallate enhances neuroregeneration after spinal cord injury by altering levels of inflammatory cytokines.
    Machova Urdzikova L; Ruzicka J; Karova K; Kloudova A; Svobodova B; Amin A; Dubisova J; Schmidt M; Kubinova S; Jhanwar-Uniyal M; Jendelova P
    Neuropharmacology; 2017 Nov; 126():213-223. PubMed ID: 28899730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial.
    Chiaverini C; Roger C; Fontas E; Bourrat E; Bourdon-Lanoy E; Labrèze C; Mazereeuw J; Vabres P; Bodemer C; Lacour JP
    Orphanet J Rare Dis; 2016 Mar; 11():31. PubMed ID: 27015660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice.
    Zhang S; Liu X; Mei L; Wang H; Fang F
    BMC Complement Altern Med; 2016 Aug; 16(1):334. PubMed ID: 27581210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of interleukin-10 on cutaneous wounds and scars in humans of African continental ancestral origin.
    Kieran I; Taylor C; Bush J; Rance M; So K; Boanas A; Metcalfe A; Hobson R; Goldspink N; Hutchison J; Ferguson M
    Wound Repair Regen; 2014; 22(3):326-33. PubMed ID: 24844332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin.
    Katiyar SK; Agarwal R; Wang ZY; Bhatia AK; Mukhtar H
    Nutr Cancer; 1992; 18(1):73-83. PubMed ID: 1408948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.
    de la Torre R; de Sola S; Farré M; Xicota L; Cuenca-Royo A; Rodriguez J; León A; Langohr K; Gomis-González M; Hernandez G; Esteba S; Del Hoyo L; Sánchez-Gutiérrez J; Cortés MJ; Ozaita A; Espadaler JM; Novell R; Martínez-Leal R; Milá M; Dierssen M;
    Clin Nutr; 2020 Feb; 39(2):378-387. PubMed ID: 30962103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bi-layer composite dressing of gelatin nanofibrous mat and poly vinyl alcohol hydrogel for drug delivery and wound healing application: in-vitro and in-vivo studies.
    Jaiswal M; Gupta A; Agrawal AK; Jassal M; Dinda AK; Koul V
    J Biomed Nanotechnol; 2013 Sep; 9(9):1495-508. PubMed ID: 23980498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scar redness in humans: how long does it persist after incisional and excisional wounding?
    Bond JS; Duncan JAL; Mason T; Sattar A; Boanas A; O'Kane S; Ferguson MWJ
    Plast Reconstr Surg; 2008 Feb; 121(2):487-496. PubMed ID: 18300967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effects of epigallocatechin gallate on compound 48/80-induced mast cell activation and passive cutaneous anaphylaxis.
    Li GZ; Chai OH; Song CH
    Exp Mol Med; 2005 Aug; 37(4):290-6. PubMed ID: 16155406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury.
    Renno WM; Benov L; Khan KM
    J Neurosurg Spine; 2017 Nov; 27(5):593-613. PubMed ID: 28777065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigallocatechin gallate (EGCG) (TEAVIGO) does not impair nonhaem-iron absorption in man.
    Ullmann U; Haller J; Bakker GC; Brink EJ; Weber P
    Phytomedicine; 2005 Jun; 12(6-7):410-5. PubMed ID: 16008116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mesenchymal stem cells in the treatment of Cesarean section skin scars: study protocol for a randomized, controlled trial.
    Fan D; Xia Q; Wu S; Ye S; Liu L; Wang W; Guo X; Liu Z
    Trials; 2018 Mar; 19(1):155. PubMed ID: 29499740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization.
    Bianchi A; Marchetti N; Scalia S
    J Pharm Biomed Anal; 2011 Dec; 56(4):692-7. PubMed ID: 21807473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Administration of a dietary supplement ( N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial.
    Rondanelli M; Opizzi A; Solerte SB; Trotti R; Klersy C; Cazzola R
    Br J Nutr; 2009 Feb; 101(3):457-64. PubMed ID: 18590587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyaluronic Acid/PLGA Core/Shell Fiber Matrices Loaded with EGCG Beneficial to Diabetic Wound Healing.
    Shin YC; Shin DM; Lee EJ; Lee JH; Kim JE; Song SH; Hwang DY; Lee JJ; Kim B; Lim D; Hyon SH; Lim YJ; Han DW
    Adv Healthc Mater; 2016 Dec; 5(23):3035-3045. PubMed ID: 27805803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice.
    Lu YP; Lou YR; Xie JG; Peng QY; Liao J; Yang CS; Huang MT; Conney AH
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12455-60. PubMed ID: 12205293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and Efficacy of a Scar Cream Consisting of Highly Selective Growth Factors Within a Silicone Cream Matrix: A Double-Blinded, Randomized, Multicenter Study.
    Zoumalan CI; Tadayon SC; Roostaeian J; Rossi AM; Gabriel A
    Aesthet Surg J; 2019 Feb; 39(3):319-330. PubMed ID: 30084900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Promotion of full-thickness wound healing using epigallocatechin-3-O-gallate/poly (lactic-co-glycolic acid) membrane as temporary wound dressing.
    Kim HL; Lee JH; Kwon BJ; Lee MH; Han DW; Hyon SH; Park JC
    Artif Organs; 2014 May; 38(5):411-7. PubMed ID: 24571533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell sheet composed of adipose-derived stem cells demonstrates enhanced skin wound healing with reduced scar formation.
    Yu J; Wang MY; Tai HC; Cheng NC
    Acta Biomater; 2018 Sep; 77():191-200. PubMed ID: 30017923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.